merck verona pharma - Search News

News

Merck shells out $10 billion for Verona

Reuters on MSN · 4d

Merck shells out $10 billion for Verona in bid to diversify beyond Keytruda

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory treatment as it faces pressure to diversify beyond its blockbuster cancer drug Keytruda.

The Wall Street Journal on MSN · 4d

Merck to Buy Verona Pharma in $10 Billion Deal

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

MarketWatch on MSN · 4d

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma

Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma’s Ohtuvayre.

2d

Merck's Verona Acquisition: Plugging A $4B Hole In A $20B Gap

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

1don MSN

Verona Pharma plc (VRNA): Jim Cramer Approves The Merck Acquisition

We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Verona Pharma plc (NASDAQ:VRNA) ...

BioPharma Dive2d

With Verona deal, Merck wagers on strength of lung drug’s patents

The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results